Physician profile
Crystal Wolf
NPI 1558805705
$931.01
in general payments reported to CMS, 2019-2025
11 companies · $82.89 in 2025
The $82.89 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $126 · 2023: $470 · 2024: $252 · 2025: $82.89.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $805.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $805.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $232.47 | 2023 | Enhertu |
| Astellas Pharma US INC | $124.97 | 2024 | Vyloy |
| Intera Oncology, INC | $113.18 | 2024 | Intera |
| Ipsen Biopharmaceuticals, INC | $113.10 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $107.60 | 2023 | |
| Abbvie INC. | $89.26 | 2023 | |
| Gilead Sciences, INC. | $37.76 | 2025 | Trodelvy |
| Merck Sharp & Dohme LLC | $30.24 | 2022-2023 | Lynparza, Keytruda |
| Taiho Oncology, INC. | $29.62 | 2024-2025 | |
| Abiomed | $29.36 | 2025 | |
| Astrazeneca Pharmaceuticals Lp | $23.45 | 2023 | Imfinzi |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Crystal Wolf listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.